About Us

About Matrivax

Matrivax is a clinical-stage biotechnology company developing human vaccines for the

prevention and treatment of life-threatening infectious diseases.

Our pipeline includes two vaccine candidates implementing proprietary protective antigens against Streptococcus pneumoniae (MVX01) and Clostridioides difficile (MVX02).

Matrivax is a privately-held company proudly based in the biotech hub of Boston, MA..